662 related articles for article (PubMed ID: 19473299)
1. Warfarin is not needed in low-risk patients following atrial fibrillation ablation procedures.
Bunch TJ; Crandall BG; Weiss JP; May HT; Bair TL; Osborn JS; Anderson JL; Lappe DL; Muhlestein JB; Nelson J; Allison S; Foley T; Anderson L; Day JD
J Cardiovasc Electrophysiol; 2009 Sep; 20(9):988-93. PubMed ID: 19473299
[TBL] [Abstract][Full Text] [Related]
2. Which is the optimal therapy to prevent thromboembolism after atrial fibrillation ablation procedures in low stroke risk patients, anticoagulation or antiplatelet therapy?
Okumura Y
J Cardiovasc Electrophysiol; 2009 Sep; 20(9):994-6. PubMed ID: 19549032
[No Abstract] [Full Text] [Related]
3. Periprocedural anticoagulation for atrial fibrillation ablation.
Mortada ME; Chandrasekaran K; Nangia V; Dhala A; Blanck Z; Cooley R; Bhatia A; Gilbert C; Akhtar M; Sra J
J Cardiovasc Electrophysiol; 2008 Apr; 19(4):362-6. PubMed ID: 18284509
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary vein antrum isolation for atrial fibrillation on therapeutic coumadin: special considerations.
Gopinath D; Lewis WR; Di Biase L; Natale A
J Cardiovasc Electrophysiol; 2011 Feb; 22(2):236-9. PubMed ID: 21044211
[TBL] [Abstract][Full Text] [Related]
6. Complications of atrial fibrillation ablation in a high-volume center in 1,000 procedures: still cause for concern?
Dagres N; Hindricks G; Kottkamp H; Sommer P; Gaspar T; Bode K; Arya A; Husser D; Rallidis LS; Kremastinos DT; Piorkowski C
J Cardiovasc Electrophysiol; 2009 Sep; 20(9):1014-9. PubMed ID: 19490383
[TBL] [Abstract][Full Text] [Related]
7. Maintenance of sinus rhythm with an ablation strategy in patients with atrial fibrillation is associated with a lower risk of stroke and death.
Hunter RJ; McCready J; Diab I; Page SP; Finlay M; Richmond L; French A; Earley MJ; Sporton S; Jones M; Joseph JP; Bashir Y; Betts TR; Thomas G; Staniforth A; Lee G; Kistler P; Rajappan K; Chow A; Schilling RJ
Heart; 2012 Jan; 98(1):48-53. PubMed ID: 21930724
[TBL] [Abstract][Full Text] [Related]
8. Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio.
Di Biase L; Burkhardt JD; Mohanty P; Sanchez J; Horton R; Gallinghouse GJ; Lakkireddy D; Verma A; Khaykin Y; Hongo R; Hao S; Beheiry S; Pelargonio G; Dello Russo A; Casella M; Santarelli P; Santangeli P; Wang P; Al-Ahmad A; Patel D; Themistoclakis S; Bonso A; Rossillo A; Corrado A; Raviele A; Cummings JE; Schweikert RA; Lewis WR; Natale A
Circulation; 2010 Jun; 121(23):2550-6. PubMed ID: 20516376
[TBL] [Abstract][Full Text] [Related]
9. Atrial fibrillation significantly increases total mortality and stroke risk beyond that conveyed by the CHADS2 risk factors.
Crandall MA; Horne BD; Day JD; Anderson JL; Muhlestein JB; Crandall BG; Weiss JP; Osborne JS; Lappé DL; Bunch TJ
Pacing Clin Electrophysiol; 2009 Aug; 32(8):981-6. PubMed ID: 19659615
[TBL] [Abstract][Full Text] [Related]
10. The CHADS score role in managing anticoagulation after surgical ablation for atrial fibrillation.
Ad N; Henry L; Schlauch K; Holmes SD; Hunt S
Ann Thorac Surg; 2010 Oct; 90(4):1257-62. PubMed ID: 20868824
[TBL] [Abstract][Full Text] [Related]
11. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial.
Di Biase L; Burkhardt JD; Santangeli P; Mohanty P; Sanchez JE; Horton R; Gallinghouse GJ; Themistoclakis S; Rossillo A; Lakkireddy D; Reddy M; Hao S; Hongo R; Beheiry S; Zagrodzky J; Rong B; Mohanty S; Elayi CS; Forleo G; Pelargonio G; Narducci ML; Dello Russo A; Casella M; Fassini G; Tondo C; Schweikert RA; Natale A
Circulation; 2014 Jun; 129(25):2638-44. PubMed ID: 24744272
[TBL] [Abstract][Full Text] [Related]
12. Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1.
Gorin L; Fauchier L; Nonin E; de Labriolle A; Haguenoer K; Cosnay P; Babuty D; Charbonnier B
Thromb Haemost; 2010 Apr; 103(4):833-40. PubMed ID: 20135077
[TBL] [Abstract][Full Text] [Related]
13. Long-term clinical efficacy and risk of catheter ablation for atrial fibrillation in the elderly.
Zado E; Callans DJ; Riley M; Hutchinson M; Garcia F; Bala R; Lin D; Cooper J; Verdino R; Russo AM; Dixit S; Gerstenfeld E; Marchlinski FE
J Cardiovasc Electrophysiol; 2008 Jun; 19(6):621-6. PubMed ID: 18462325
[TBL] [Abstract][Full Text] [Related]
14. Safety and convenience of continuous warfarin strategy during the periprocedural period in patients who underwent catheter ablation of atrial fibrillation.
Kwak JJ; Pak HN; Jang JK; Kim SK; Park JH; Choi JI; Hwang C; Kim YH
J Cardiovasc Electrophysiol; 2010 Jun; 21(6):620-5. PubMed ID: 20039992
[TBL] [Abstract][Full Text] [Related]
15. Newly detected atrial fibrillation and compliance with antithrombotic guidelines.
Glazer NL; Dublin S; Smith NL; French B; Jackson LA; Hrachovec JB; Siscovick DS; Psaty BM; Heckbert SR
Arch Intern Med; 2007 Feb; 167(3):246-52. PubMed ID: 17296879
[TBL] [Abstract][Full Text] [Related]
16. Risk of bleeding in very old atrial fibrillation patients on warfarin: relationship with ageing and CHADS2 score.
Poli D; Antonucci E; Marcucci R; Fatini C; Alterini B; Mannini L; Falciani M; Abbate R; Gensini GF; Prisco D
Thromb Res; 2007; 121(3):347-52. PubMed ID: 17597186
[TBL] [Abstract][Full Text] [Related]
17. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy.
Hohnloser SH; Pajitnev D; Pogue J; Healey JS; Pfeffer MA; Yusuf S; Connolly SJ;
J Am Coll Cardiol; 2007 Nov; 50(22):2156-61. PubMed ID: 18036454
[TBL] [Abstract][Full Text] [Related]
18. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
[TBL] [Abstract][Full Text] [Related]
19. Periprocedural stroke risk in patients undergoing catheter ablation for atrial fibrillation on uninterrupted warfarin.
Page SP; Herring N; Hunter RJ; Withycombe E; Lovell M; Wali G; Betts TR; Bashir Y; Dhinoja M; Earley MJ; Sporton SC; Rajappan K; Schilling RJ
J Cardiovasc Electrophysiol; 2014 Jun; 25(6):585-90. PubMed ID: 24641450
[TBL] [Abstract][Full Text] [Related]
20. Mortality after catheter ablation for atrial fibrillation compared with antiarrhythmic drug therapy. A meta-analysis of randomized trials.
Dagres N; Varounis C; Flevari P; Piorkowski C; Bode K; Rallidis LS; Tsougos E; Leftheriotis D; Sommer P; Hindricks G; Kremastinos DT
Am Heart J; 2009 Jul; 158(1):15-20. PubMed ID: 19540387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
